Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news

Show

From To
HIV Microbicides Require Safety, Efficacy, Good Marketing

Designing a successful topical microbicide against HIV must balance efficacy and toxicity. Microbicides are intended to cut down the risk for transmission of HIV, and they may give a measure of control to people whose partners do not use condoms.

Published
30 October 2013
From
Medscape (requires free registration)
IPM Receives Two Awards from USAID to Advance HIV Prevention Technologies for Women

The International Partnership for Microbicides (IPM) announced today that it has received two competitive five-year awards with a combined US$40 million ceiling from the US Agency for International Development (USAID). Both awards aim to advance new HIV prevention tools for women and to help ensure their availability in developing countries where the epidemic has hit hardest.

Published
22 October 2013
From
International Partnership for Microbicides
Researchers and advocates discuss the microbicides pipeline in Europe

The first day of the 14th European AIDS Conference, which opened yesterday in Brussels, featured a satellite symposium on development of HIV microbicides, broadly defined to include a

Published
17 October 2013
By
Liz Highleyman
Microbicide ring study shows users are reassured about discomfort but develop new worries about safety

A safety and acceptability study of a vaginal ring containing the antiretroviral drugs dapivirine (TMC120) and/or maraviroc (Celsentri, Selzentry) shows that women using the ring generally found

Published
03 October 2013
By
Gus Cairns
Researchers launch first-ever phase II safety study of rectal microbicide to prevent HIV

Taking an important step toward the development of a product to prevent HIV infections associated with unprotected anal sex, researchers today announced the launch of a global Phase II clinical trial of a potential rectal microbicide. The trial, led by the US National Institutes of Health-funded Microbicide Trials Network, is testing the rectal use of a reduced glycerin gel formulation of the antiretroviral drug tenofovir.

Published
03 October 2013
From
Eurekalert Inf Dis
Tenofovir vaginal ring protects monkeys on Depo-Provera against HIV-like virus

An intravaginal ring containing tenofovir protected all but one macaque monkey given hormonal contraceptives and repeatedly exposed to a hybrid human/simian virus similar to HIV, according to

Published
30 September 2013
By
Liz Highleyman
South American survey finds rectal microbicide formulated as a douche acceptable

A qualitative study of 140 men who have sex with men (MSM) and transgender women (TGW) in three cities in Peru and Ecuador has found

Published
18 September 2013
By
Gus Cairns
Partner violence may undermine use of female-controlled forms of HIV prevention

Women who experience violence from their male partner are less likely to use condoms or diaphragms, an international team of investigators report in the online edition of the

Published
27 August 2013
By
Michael Carter
UNITAID launches first-ever comprehensive report on HIV prevention products

The rate of new HIV infections in adults and adolescents has not fallen since 2007 but an unprecedented range of new products to prevent transmission of the disease could reduce the 2.5 million new HIV infections each year if they are made affordable, according to a report released today by UNITAID.

Published
27 August 2013
From
UNITAID
IPM Receives £15 Million from UK Government to Advance Innovative Health Products for Women

Funding will accelerate development of HIV prevention tools and other sexual and reproductive health technologies.

Published
22 August 2013
From
International Partnership for Microbicides

Filter by country